About Medical Cells Network:
Who We Are and Why It Matters
Medical Cells Network is an independent international advisory service specialising in stem cell and exosome therapies. We are not a clinic. We do not administer treatments.
What we do is guide patients and families through one of the most complex and rapidly evolving areas of modern medicine - helping them access regulated, evidence-based regenerative medicine programmes with clarity, honesty, and rigorous scientific grounding.
Our advisory team combines over 12 years of experience in regenerative medicine with direct clinical expertise in stem cell protocols. To date we have supported more than 1,100 patients.
A Personal Mission
I founded Medical Cells Network because I saw a gap that nobody was filling properly.
Patients with serious neurological conditions - Autism, Cerebral Palsy, Parkinson's, MS, ALS, Alzheimer's - were navigating a landscape full of contradictions.
On one side, genuinely promising science advancing rapidly in clinical trials. On the other, a market flooded with unregulated providers making extraordinary claims with no evidence behind them.
Families were either told by their doctors that nothing could be done, or they fell prey to clinics offering false hope at enormous cost. Neither outcome was acceptable to me.
My background is in international healthcare advisory as well as clinic investments and management. Over more than a decade I built a network of relationships with leading researchers, clinicians, and regulated treatment centres in the field of regenerative medicine.
Medical Cells Network was founded to put that network to work for patients - providing the kind of rigorous, honest, independent guidance that was simply not available elsewhere.
Treatment protocols are available in Germany, Switzerland, and Georgia, with the specific programme and cell type determined by each patient's indication, disease stage, and individual medical assessment.
Our reach is global: patients consult with us from every continent, and we have managed successful treatments for patients from the European Union, UAE, Thailand, China, Ireland, Australia, Saudi Arabia, and many other countries.
Boris Haller - CEO and Founder
Our Approach - Independent Advisory,
Not a Clinic
We are advisors, not providers. That independence is the foundation of everything we do.
When a patient comes to us, we start with a thorough review of their medical history, diagnosis, and current treatment.
We assess whether stem cell or exosome therapy is likely to be beneficial based on the published clinical evidence for their specific condition and disease stage. If we do not believe the evidence supports treatment, we say so.
We accompany patients through every step: pre-treatment preparation, the treatment programme itself, and remote follow-up at 1, 3, and 6 months after treatment.
Our Medical Team
Our advisory board includes board-certified physicians and researchers with specialist expertise in neurology, genetics, immunology, oncology and regenerative medicine.
Our lead physician has over 20 years of direct clinical experience in stem cell protocols and has been instrumental in developing the evidence-based German-protocol programme we use today.
We maintain deliberate discretion about the identities of our medical team members. This reflects the complex regulatory environment surrounding advanced cell therapies in Europe, where public association with treatments not yet approved under national frameworks can create professional difficulties for individual physicians - regardless of the scientific merit of the therapies or the regulatory legitimacy of the treatment locations.
What we can tell you is that every patient case is reviewed by qualified medical specialists, and that our protocols are grounded in peer-reviewed clinical evidence.
Get in touch
If you would like to discuss whether stem cell or exosome therapy may be appropriate for your situation, we welcome your enquiry. All initial consultations are confidential and carry no obligation.
